Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) have been assigned an average rating of “Hold” from the six brokerages that are currently covering the firm, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $119.54.
A number of analysts have issued reports on USPH shares. Zacks Investment Research reissued a “buy” rating and issued a $145.00 price objective on shares of U.S. Physical Therapy in a report on Saturday, October 5th. ValuEngine downgraded shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd.
NYSE USPH traded up $1.33 during trading on Thursday, reaching $134.03. The company’s stock had a trading volume of 7,669 shares, compared to its average volume of 73,332. The company has a current ratio of 1.88, a quick ratio of 1.88 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $1.69 billion, a price-to-earnings ratio of 50.66, a price-to-earnings-growth ratio of 3.65 and a beta of 1.12. U.S. Physical Therapy has a 12 month low of $98.69 and a 12 month high of $138.58. The firm has a 50 day moving average price of $131.91 and a 200 day moving average price of $122.69.
In other news, Director Mark J. Brookner sold 3,000 shares of the company’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $134.84, for a total transaction of $404,520.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Christopher J. Reading sold 7,000 shares of the company’s stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $135.13, for a total transaction of $945,910.00. The disclosure for this sale can be found here. Insiders sold a total of 22,803 shares of company stock valued at $3,067,830 in the last three months. Insiders own 2.50% of the company’s stock.
Several institutional investors have recently modified their holdings of USPH. EULAV Asset Management increased its position in U.S. Physical Therapy by 11.3% during the 2nd quarter. EULAV Asset Management now owns 71,700 shares of the company’s stock worth $8,788,000 after purchasing an additional 7,300 shares in the last quarter. GSA Capital Partners LLP acquired a new position in U.S. Physical Therapy during the 2nd quarter worth approximately $712,000. AE Wealth Management LLC increased its position in U.S. Physical Therapy by 61.4% during the 2nd quarter. AE Wealth Management LLC now owns 4,369 shares of the company’s stock worth $536,000 after purchasing an additional 1,662 shares in the last quarter. LPL Financial LLC acquired a new position in U.S. Physical Therapy during the 2nd quarter worth approximately $227,000. Finally, Great Lakes Advisors LLC increased its position in U.S. Physical Therapy by 2.5% during the 2nd quarter. Great Lakes Advisors LLC now owns 44,705 shares of the company’s stock worth $5,480,000 after purchasing an additional 1,079 shares in the last quarter.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Read More: What is the NASDAQ?
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.